Non-suppressible TSH in a patient thyroidectomized due to follicular thyroid carcinoma

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 7, 2006, Pages 389-392

  Gessl, Alois ^a   Vierhapper, H ^a   Feichtinger, H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Donauspital Wien ^*  (Austria)

Author keywords

Cancer; Pituitary adenoma; Thyrotropin

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADULT; FEMALE; HUMANS; PITUITARY GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TREATMENT OUTCOME;

EID: 33747602336     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924327     Document Type: Article

References (16)

1. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17: 610-638
2. Bell DS, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract 2001; 7: 193-194
3. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 1999; 84: 476-486
4. Calle-Pascual AL, Yuste E, Martin P, Aramendi T, Garcia-Maurino ML, Argente J, Catalan MJ, Uria J, Cabranes JA, Charro AL. Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular carcinoma. J Endocrinol Invest 1991; 14: 499-502
5. Gasparoni P, Rubello D, Persani L, Beck-Peccoz P. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma. Thyroid 1998; 8: 181-183
6. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H. Growth Hormone-Prolactin-Thyrotropin-Secreting Pituitary Adenoma in Atypical McCune-Albright Syndrome with functionally normal Gsα-Protein. J Clin Endocrinol Metab 1994; 79: 1128-1134
7. Kishida M, Otsuka F, Kataoka H, Yokota K, Oishi T, Yamauchi T, Doihara H, Tamiya T, Mimura Y, Ogura T, Makino H. Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma. Endocr J 2000; 6: 731-738
8. Liel Y, Harman-Boehm I, Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab 1996; 81: 857-859
9. Lips DJ, van Reisen MT, Voigt V, Venekamp W. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med 2004; 62: 114-118
10. McDermott JH, Cross A, Walsh CH. Celiac disease presenting as resistant hypothyroidism. Thyroid 2005; 15: 386-388
11. Ohta S, Nishizawa S, Oki Y, Namba H. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid - a case report and surgical strategy. Pituitary 2001; 4: 271-274
12. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med 2005; 353: 487-497
13. Pujol B, Daures JP, Nsakala N, Baldet L, Bringer J, Affiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid carcinoma. J Clin Endocrinol Metab 1996; 81: 4318-4340
14. Refetoff S, Weiss RE, Usala SJ. The syndrome of resistance to thyroid hormone. Endocr Rev 1993; 14: 348-399
15. Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Arch Intern Med 2003; 163: 1367-1370
16. Toft AD. Thyroxine therapy. New Engl J Med 1994; 331: 174-180